Parties d'ouvrages collectifs (6)
  1. 1. Simones, T., Shepherd, D. D., & Moser, M. (2010). Dendritic Cells. In C. A. McQueen & D. Lawrence (Eds.), Comprehensive Toxicology, Vol. 5. Immune System Toxicology (2 ed., pp. 155-170). Oxford: Elsevier Inc. doi:10.1016/B978-0-08-046884-6.00608-4
  2. 2. Moser, M. (2008). Dendritic cells. In W. Paul (Ed.), Fundamental immunology. Philadelphia, USA: Lippincott Williams and Wilkins.
  3. 3. De Heusch, M., Oldenhove, G., & Moser, M. (2006). Dendritic Cells (DCs) in Immunity and Maintenance of Tolerance. In H. Kropshofer & A. Vogt (Eds.), Antigen Presenting Cells: From Mechanisms to Drug Development (pp. 503-522). Wiley-VCH Verlag GmbH & Co. KGaA. doi:10.1002/3527607021.ch14
  4. 4. Moser, M. (2006). Antigen presentation, dendritic cells and autoimmunity. In N. Rose & I. Mackay (Eds.), The autoimmune diseases (pp. 37-46). Academic Press. doi:10.1016/B978-012595961-2/50007-X
  5. 5. Moser, M. (2003). Dendritic cells. In W. Paul (Ed.), Fundamental immunology (5 ed., pp. 455-480). Philadelphia, USA: Lippincott Williams and Wilkins.
  6. 6. Urbain, J., Vansanten, G., Demeur, C., Leo, O., Marvel, J., Moser, M., Tassignon, J., & Slaoui, M. (1986). From idiotypes to idiotypic network. In J. D. Capra & M. Reichlin (Eds.), Intern. Conference on Idiotypes (pp. 111-138). Acad. Press.
    7.   Articles dans des revues avec comité de lecture (138)
  7. 1. Bowakim-Anta, N., Acolty, V., Azouz, A., Yagita, H., Leo, O., Goriely, S., Oldenhove, G., & Moser, M. (2023). Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs. Frontiers in immunology, 14, 1023064. doi:10.3389/fimmu.2023.1023064
  8. 2. Mirzaei, M., Dodi, G., Gardikiotis, I., Pasca, S.-A., Mirdamadi, S., Subra, G., Echalier, C., Puel, C., Morent, R., Ghobeira, R., Soleymanzadeh, N., Moser, M., Goriely, S., & Shavandi, A. (2023). 3D high-precision melt electro written polycaprolactone modified with yeast derived peptides for wound healing. Biomaterials Advances, 149, 213361. doi:10.1016/j.bioadv.2023.213361
  9. 3. Bisilliat Donnet, C., Acolty, V., Azouz, A., Taquin, A., Henin, C., Cafarello, S. T., Denanglaire, S., Mazzone, M., Oldenhove, G., Leo, O., Goriely, S., & Moser, M. (2023). PHD2 Constrains Antitumor CD8+ T-cell Activity. Cancer immunology research, 11(3), 339-350. doi:10.1158/2326-6066.CIR-22-0099
  10. 4. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  11. 5. Vogel, I., Acolty, V., Keler, T., Goriely, S., Leo, O., & Moser, M. (2022). Agonistic anti-CD27 antibody ameliorates EAE by suppressing IL-17 production. European Journal of Immunology, 52(10), 1620-1629. doi:10.1002/eji.202149698
  12. 6. Mirzaei, M., Shavandi, A., Dodi, G., Gardikiotis, I., Pasca, S.-A., Mirdamadi, S., Soleymanzadeh, N., Alimoradi, H., Moser, M., & Goriely, S. (2022). A Yeast-Derived Peptide Promotes Skin Wound Healing by Stimulating Effects on Fibroblast and Immunomodulatory Activities. SSRN Electronic Journal. doi:10.2139/ssrn.4030328
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>